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THE EFFECT OF ELECTRONIC NICOTINE DELIVERY SYSTEMS ON THE
VOCAL FOLDS
HILARY SAMPLE
ABSTRACT
Electronic Nicotine Delivery Systems (ENDS) are non-combustible tobacco
products that are rapidly gaining in popularity worldwide. ENDS are marketed as safer
alternatives to cigarettes; however, very little research is available to support or deny
these claims. ENDS aerosol is inhaled over the vocal folds and into the lungs consistent
with cigarette smoke. The larynx is among the primary locations affected by smoking;
therefore, it is necessary to evaluate the effect, if any, of ENDS on the larynx.
The goal of the present study was to evaluate the laryngeal appearance and
function of seven ENDS users as compared to four cigarette smokers. A control group of
six nonsmokers was included in this study. Vocal tasks were assessed through acoustic
analysis and videostroboscopy. No significant relationship was found between ENDS use
and abnormal acoustic measures; however, data compared to norms for age and gender
revealed a pattern of raised shimmer percent among ENDS users and smokers.
Videostroboscopic analysis revealed significant relationships between ENDS use and
abnormal mucosal wave, free edge, phase closure, vocal fold varices and vocal fold
edema, as well as a marginally significant relationship between ENDS use and abnormal
phase symmetry. These results indicate that ENDS use may have a significant effect on
laryngeal structures and their function.
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CHAPTER I
INTRODUCTION

Electronic Nicotine Delivery Systems (ENDS), also termed electronic cigarettes,
e-cigarettes, and e-cig, are non-combustible tobacco products that are rapidly gaining in
popularity since their introduction into the global market in 2004. ENDS are hand-held
battery-powered devices that heat a solution, termed “e-liquid” to generate an aerosol,
which is then inhaled. ENDS were designed to substitute cigarettes by providing a
similar physical and sensory experience to that of smoking (Asgharian, Price, Rostami &
Pithawala, 2018; Chapman & Wu, 2014). ENDS is perceived as a safer alternative to
cigarettes (Chapman & Wu, 2014); however, very few studies exist on the effects of
ENDS use, and limited research is available to either prove or disprove these assertions.
Following a puff, ENDS aerosol is delivered over the vocal folds and into the
lungs. The remaining aerosol is exhaled back over the vocal folds, through the oral
cavity, and into the environment (Cheng, 2014). The aerosol travels through the
respiratory tract in the same manner as conventional cigarettes. The larynx, which is
located in the upper respiratory tract, has been examined histologically, acoustically, and
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perceptually to determine health effects after exposure to cigarette smoke.
Researchers have found that the larynx, especially the true vocal folds, is the main site
affected by inhalation of cigarette smoke (Auerbach, Hammond, & Garfinkel, 1970;
Kelleher, Siegmund, & Chan, 2014).
Numerous studies have been conducted that describe anatomical and
physiological changes in the vocal folds and larynges of smokers that occurs as a result of
smoking (Myerson, 1964; Auerbach et al., 1970; Awan & Morrow, 2007; Banjara,
Mungutwar, Singh, & Gupta, 2011; Kelleher, Siegmund, & Chan, 2014; Öğüt & Kiliç,
2013; Stanciu & Bennett, 1972). It is reasonable to believe the same anatomical
structures most impacted by cigarette smoke exposure may also be impacted by ENDS
aerosol exposure. However, due to the recent availability of ENDS on the United States
market, research is extremely limited on the effects of long-term chronic ENDS exposure
on the larynx. Therefore, evaluation of ENDS users’ laryngeal anatomy and physiology
is necessary to assess the effects, if any, of ENDS on the human larynx.
ENDS Devices
ENDS devices have three basic parts: a rechargeable lithium battery, an atomizer,
and a reservoir, cartridge or pod, which contains e-liquid. Activation of the heating coil
within the atomizer transforms the e-liquid into nicotine aerosol (Kaisar, Prasad, Liles &
Cucullo, 2016). ENDS devices may have either an airflow sensor or a manual trigger
that activates a heating coil. The heating coil raises the temperature of the atomizer,
which produces an aerosol from the e-liquid. The aerosol is then puffed through a
mouthpiece connected to the e-liquid cartridge (Figure 1.2). There are two types of
ENDS: open and closed systems. These are also referred to as open and closed tank
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respectively. The cartridge or tank is refillable in open system devices, and the cartridge
is disposable and prefilled with e-liquid in closed system devices.
The design, technical characteristics and operation of ENDS are rapidly evolving.
Technical characteristics include the maximum battery output, temperature of the heat
coil, and the ability to modify the device. Advances in technical characteristics over time
differentiate devices into subtypes or “generations”. The four main subtypes of ENDS
devices include: disposable cigalike, rechargeable cigalike, rechargeable vaporizers, and
rechargeable pod systems (Glasser et al., 2017).
Disposable Cigalikes. Disposable cigalikes are single-use first-generation devices
that closely resemble cigarettes, complete with a light emitting diode (LED) at the tip that
is activated when a user inhales (Figure 1.1). These electronic cigarettes are neither
rechargeable nor refillable. Disposable cigalikes are discarded in their entirety when eliquid is depleted. The low voltage battery is activated by an airflow sensor when the user
inhales, which then activates the heating coil, resulting in aerosol production.

Figure: 1.1 Disposable/rechargeable cigalike components
(From Choosing the Right Type of Electronic Cigarette (Vape). (2014, March 1). Retrieved January 13,
2019, from Vaporferver website: https://vaporferver.com/electronic-cigarette-info/choosing-the-right-typeof-electronic-cigarette/)

Rechargeable cigalikes. Rechargeable cigalikes closely resemble disposable
cigalikes but include a rechargeable battery (Figure 1.1). Rechargeable cigalikes are
second generation devices that have two options: manual trigger or airflow sensor. With
an airflow sensor, otherwise termed “automatic draw”, the battery is activated by
3

inhalation and requires a disposable cartomizer. A cartomizer is a combined unit for both
the atomizer and pre-filled cartridge. The battery for manual trigger, also termed “manual
draw”, is activated by pressing a button.
Rechargeable vaporizers. Rechargeable vaporizers are third-generation devices
that do not resemble cigarettes and include “vape pens” (Figure 1.2), “mods” and “box
mods” (Figure 1.3). These rechargeable devices are open tank systems. They are larger
than cigalikes with modifiable, higher voltage batteries and more advanced atomizers.
With refillable reservoirs, users have the option to customize e-liquid. These devices are
either variable voltage or temperature controlled. Variable voltage devices have
modifiable batteries, which allow the user to modify the device voltage and temperature
of the coil. Increasing the temperature of the coil alters the density and “hit” of the
aerosol, creating a similar physical sensation to cigarette smoke inhalation.

Figure 1.2 Systematic illustration of rechargeable vape pen
(From Kaisar et al., 2016)
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Figure 1.3 schematic illustration of components of a “box mod” rechargeable vaporizer
E-Cig 101 - Informative and Always Tuition Free! (n.d.). Retrieved January 13, 2019, from
https://www.nicotinenirvana.com/ecig-101-s/12.htm

Rechargeable pod systems. Rechargeable pod systems are current generation
devices that come in a multitude of designs (Figure 1.4). These devices may be usermodifiable, are rechargeable, and are either open tank or close tank systems. Devices may
be variable voltage or temperature controlled. Temperature controlled models allow the
user to program a fixed temperature into the microchip for a consistent aerosol output.
Rechargeable pods include brands like “Suorin Drop”, “myblu”, and “Juul”.
Juul has become its own category of vape devices and users, especially within the
adolescent and 18-25-year old young adult population, who now replace the verb
“vaping” with “juuling” (Huang et al., 2018). The voltage of these devices is controlled
application, meaning that users cannot modify voltage output. The amount of nicotine per
e-liquid pod is approximately equivalent to one pack of cigarettes or 200 puffs (Kee,
2018; Huang et al., 2018; Dawkins, Kimber, Puwanesarasa & Soar, 2015).

5

Figure 1.4 Rechargeable pod schematic illustration of juul components
from King County - E-cigarettes and vaping products (n.d.). Retrieved January 13, 2019, from
https://www.kingcounty.gov/~/media/depts/health/tobacco-vapor/images/juul-diagram-carousel.ashx

ENDS Regulation and Standardization
The U.S. Food and Drug Administration (FDA) has authority to regulate tobacco
products, and in 2016, extended that regulatory authority to ENDS products; however,
the ENDS industry has an extended deadline of 2022 to comply with new FDA
guidelines (US Food and Drug Administration, 2016; Zare, Nemati & Zheng, 2018). Just
as the FDA heavily regulates cigarettes, including flavor, nicotine levels, and the number
of cigarettes per pack, it will potentially regulate ENDS attributes, including but not
limited to flavors, nicotine strength, and e-liquid size and contents. At the present time,
ENDS products are not standardized and are not yet required to conform to regulatory
guidelines. Due to the lack of regulation and standardization of ENDS devices, e-liquids
and devices with the same name and the same listed ingredients have shown
inconsistencies in contents, including nicotine, when examined by researchers (Etter,
Zather, & Svensson, 2013; Famele et al., 2015; Goniewicz et al., 2015; Goniewicz,
Hajek, & McRobbie, 2014; Goniewicz, et al., 2014; Hahn et al, 2014; Lisko et al, 2016;
Kaisar et al., 2016 ).
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ENDS Toxicity
ENDS e-liquid contains nicotine, a carrier liquid, such as vegetable glycerin and
propylene glycol, and any number of flavoring agents that make up thousands of
available flavors (Zhu, Sun, Bonnevie, Cummins, Gamst, Yin & Lee, 2014; Soussy, ElHellani, Baalbaki, Salman, Shihadeh & Saliba, 2016). Research on the chemical
composition of ENDS e-liquid and aerosol has revealed substances that are known to be
harmful in cigarette smoke (Kosmider et al, 2014; Fowels & Dybing, 2003).
Additionally, toxicity of ENDS aerosol has been shown to increase relative to increased
sweetener concentration and increased heat due to high battery voltage output (Kosmider
et al, 2014).
Toxins contained in e-liquids and aerosol. Research on the chemical
composition of ENDS has found heavy metals, carcinogens and teratogenic agents,
including carbonyl compounds, aldehydes, volatile organic compounds, and tobaccospecific nitrosamines present in ENDS e-liquid and aerosol (Farsalinos et al., 2013;
Tierney, Karpinski, Brown, Luo & Pankow, 2016; Kaisar et al., 2016). The majority of
ENDS contain vegetable glycerin and propylene glycol as carrier liquids. These
substances are ‘generally recognized as safe’ (GRAS) by the Flavor Extracts
Manufacturer’s Association (FEMA); however, this perception refers primarily to the
effect of ingestion on the digestive tract. Chronic exposure of aerosolized forms of these
substances may affect the airway differently. This may include reducing the consistency
of fluid in the tissue or exposing the tissue of the airway to harmful toxins formed during
the heating process (Callahan-Lyon, 2014; Kosmider, Sobczak, Fik, Knysak, Zaciera,
Kurek, Goniewicz, 2014).
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Propylene glycol and vegetable glycerin both thermally degrade to toxic carbonyl
compounds (Laino, Tuma, Moor, Martin, Stolz & Curioni, 2012; Kosmider et al., 2014;
IARC, 2012). Acetone and aldehydes, including formaldehyde, benzaldehyde, and
acrolein, among others, found within ENDS aerosol are formed during the heating
process (Kosmider et al., 2014). Acetone is a known mucous membrane irritant (Buron,
Hacquemand, Pourie, & Brand, 2009), and aldehydes and heavy metals have been shown
to have cytotoxic effects on epithelium (Rowell & Taran, 2015). Formaldehyde is
classified as a Group 1 human carcinogen by the International Agency for Research of
Cancer, and acetaldehyde is classified as Group 2B, possibly carcinogenic to humans
(IARC, 2012). Acrolein has been found to cause irritation in the nasal cavity and damage
to pleural lining (U.S. EPA, 2003). Exposure to carbonyls causes mouth and throat
irritation (Bullen et al, 2010), which are among the most highly reported side-effects of
ENDS exposure.
Flavored ENDS e-liquids. Surveys show that sweet and fruit flavors are
preferred by ENDS users over other options (Zare et al., 2018). A study by Welz et al.
(2018) found that fruit flavored e-liquids showed higher toxicity than tobacco flavored eliquids (Welz et al., 2018). Sweeteners used in ENDS thermally degrade to toxic
compounds including furans, 5-hydroxymethylfurfural (HMF) and furfural (FA) (Soussy
et al., 2016; Jing & Lü, 2008; Fiore et al., 2012). These flavoring agents have been shown
to cause irritation and inflammation to the human respiratory tract (Arts, Muijser, Appel,
Frieke, Bessems, Woutersen, 2004; Farsalinos, et al., 2013).
Flavoring agents have been found in “higher-than-safety” levels in a large portion
of sweet-flavored e-liquids (Allen et al, 2015). Chronic inhalation of sweeteners may lead
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to respiratory complications due to irritation and inflammation, with a potentially similar
effect on the larynx. Finally, levels of furans and other toxic compounds have been
shown to increase relative to increased heat and sweetener concentration (Soussy et al.,
2016).
ENDS battery output voltage. Increased battery output voltage affects the yield
and toxicity of ENDS aerosols (Breland, Soule, Lopez, Ramôa, El-Hellani, &
Eissenberg., 2017). First generation devices produce voltage at an average of 3.7 Volts
(V). Second generation devices produce voltage at an average of 3-6V. Current
generation devices can produce voltage of up to 8V. Studies on early or first generation
devices showed that ENDS contain fewer toxic and carcinogenic compounds than
conventional cigarettes (Goniewicz et al., 2014; Laugesen, 2008; Uchiyama, Inaba, &
Kunugita, 2010); however, these studies were unable to take into account increases in
ENDS power output ability beginning with later developed second generation devices.
Kosmider et al. (2014) found that the amount of aerosol generated by a device is
directly proportional to the power of the device battery. Many later generations of ENDS
products are variable voltage, which allow users to increase battery output voltage,
resulting in increased aerosol density in each inhalation (Rowell & Taran, 2015).
Increasing battery output voltage leads to an increased temperature of the heating coil
within ENDS. The user presses and holds an on/off switch, which sends a signal to the
heating coil, theoretically allowing the user to raise the temperature of the atomizer up to
662 degrees Fahrenheit (Balhas, Talih, Eissenberg, Salman, Karaoghlanian, Shihadeh,
2014).
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Increased battery output voltage has been shown to rapidly increase carbonyl
levels within ENDS aerosol (Kosmider et al., 2014). Additionally, the increased battery
output voltage results in more e-liquid consumed per puff, so users are not only exposed
to increased levels of carbonyls but generally greater amounts of toxins due to increased
density of the aerosol (Havel, Benowitz, Jacob & St.Helen, 2016; Kosmider et al., 2014;
Floyd, Queimado, Wang, Regens & Johnson, 2018). Kosmider et al (2014) found that
increasing voltage from 3.2 to 4.8V resulted in an increase of formaldehyde,
acetaldehyde and acetone levels of up to and over 200 times what it was in ENDS aerosol
produced at 3.2V. Havel et al. (2016) found that levels of acetaldehyde, acrolein, and
formaldehyde increased rapidly at voltages at or above 5V. Kosmider et al. (2014) found
that vapors from high voltage devices, with voltage at or above 4.9V, produce levels of
formaldehyde that are in the range of levels reported in tobacco smoke.
Reported health effects of ENDS. Most reported adverse effects of ENDS
concern the mouth, throat, and respiratory systems (World Health Organization, 2015). In
a 2012 study by Vardavas et al., researchers found that ENDS had an immediate adverse
physiologic effect after short term use similar to effects caused by cigarette use and found
that acute ENDS exposure may impair lung function (Vardavas, Anagnostopoulos,
Kougias, Evangelolpoulou, Connolly & Behrakis, 2012). Lerner et al. (2015) found that
ENDS aerosols were found to induce oxidative stress on human lung epithelial cells and
trigger an inflammatory response (Lerner, Sundar, Yao, Gerloff, Ossip, McIntosh,
Robinson, Rahman, 2015; Wu, Jiang, Minor, & Chu, 2014). A study on the effect of PG
mist revealed dry throat and cough with both acute and chronic exposure (Varughese,
Teschke, Brauer, Chow, van Netten, Kennedy, 2005). Additionally, e-liquids were found
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to be cytotoxic to oropharyngeal tissue. The epithelium of the oropharynx is similar to the
tissue within the larynx (Welz et al., 2018), which allows the possibility of a similar
effect on laryngeal structures.
Anatomy and Physiology of the Larynx
The human vocal folds are located within the larynx, which is anatomically
positioned at the top of the trachea at the levels of the cervical vertebrae 3 through 6 (C3
– C6) in adults (Figure 1.5). Healthy vocal folds are required for airway protection,
respiration, swallowing, and phonation or voicing. To produce phonation, the airstream
passes between the two vocal folds that come together and vibrate due to both myoelastic
and aerodynamic forces (Figure 1.6).

Figure 1.5 Sagittal view of vocal folds within larynx positioned at level of C3-C6
(From: Airway Management. (n.d.). Retrieved January 13, 2019, from LSU Health shreveport website:
https://LSUHealthShreveport/departments/ClinicalDepartments/OralandMaxillofacial/omfsservesprovided/
airwaymanagment/OMFSAirway.aspx)
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Figure 1.6 Vocal fold vibration caused by airstream from the lungs in anterior view
(From Understanding Voice Production. (2013, August 31). Retrieved January 13, 2019, from THE VOICE
FOUNDATION website: https://voicefoundation.org/health-science/voice-disorders/anatomy-physiologyof-voice-production/understanding-voice-production/)

True vocal fold anatomy. The vocal folds consist of 3 layers: the epithelium of
the mucosa, the lamina propria, and the vocalis muscle, with blood vessels interwoven
throughout. The lamina propria is further divided into three layers: superficial,
intermediate and deep. The epithelium is composed of squamous stratified epithelium.
The superficial lamina propria (SLLP), or Reinke’s space, is an underlying layer of loose
connective tissue (Figure 1.7). The epithelium and Reinke’s space make up the mucosal
cover, which can be observed moving during vocal fold vibration. The movement of the
mucosal cover during vocal fold vibration is known as the mucosal wave. The cover
gives the vocal folds their pearly-white appearance. The mucosal cover enfolds the vocal
ligament and the vocalis muscle. The intermediate and deep layers of the lamina propria
make up the vocal ligament. The vocal ligament is the elastic component of the vocal
folds. Reinke's space and the underlying vocal ligament together constitute the lamina
propria.
12

Figure 1.7 Coronal cross-section of a vocal fold (left) and three-dimensional model of the layers (right).
From Elsevier. Finck C, Lejeune L. Structure and oscillatory functions of the vocal fold. In: Stefan M.
Brudzynski, ed. The Handbook of Mammalian Vocalization: An Integrative Neuroscience Approach.
Chapter 10.2. Figure 2. Copyright Elsevier (2009)

Changes in vocal fold tissue influence the function of the vocal folds for voice
production. The epithelial surface of the vocal folds is covered by a thin layer of
fluid/mucus, which influences the biomechanics of vocal fold vibration (Leydon,
Sivansanker, Lodewyck, Atkins, & Fisher, 2009). This thin layer of fluid/mucus is
continuous with the tongue, pharynx, and trachea and is covered with sensory receptors
and mucus-secreting glands. Irritation or drying of this mucosa can lead to a hoarse vocal
quality, or when severe, the epithelial cells within this lining can become malignant.
Reinke's space also plays a major role in the vibration of the vocal folds (Hirano, 1980,
1981). Movement of the epithelium and Reinke’s space form the mucosal wave. During
vocal fold vibration, the mucosal wave periodically interrupts expiratory airflow,
resulting in phonation. If the mucosal cover is stiff/resists movement or is overly pliable,
this will alter the resulting tone produced by the wave. The majority of vocal fold
pathologies develop in Reinke’s space, and include polyps, nodules, and edema. The
13

accumulation of fluid/swelling in Reinke’s space due to irritation, such as smoking, is
termed “Reinke’s Edema”.
Laryngeal cartilages. The larynx, or voice box, consists of nine cartilages,
which are connected via ligaments and muscle (Figure 1.8). These include three unpaired
and three paired cartilages. The large unpaired cartilages include the epiglottis, cricoid,
and thyroid, which form the body of the larynx (Figure 1.9). The three paired cartilages
include the corniculates, arytenoids, and cuneiforms. The cricoid, thyroid and the
arytenoids have an important role in the phonatory function of the larynx. The small
paired cartilages, corniculates and cuneiforms, have a minimal role in voicing, and the
primary role of the epiglottis is airway protection.

Figure 1.8 Laryngeal cartilages
(From Team, H. J. (2017, October 5). Pharynx - Anatomy & Function in Respiratory System. Retrieved
January 26, 2019, from Health Jade website: https://healthjade.com/what-is-the-pharynx/)
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Figure 1.9 Aerial anterior view of epiglottis, cricoid and thyroid cartilages forming body of the larynx.
(From: ELLO. (n.d.). Retrieved January 27, 2019, from https://zentrum.virtuos.uniosnabrueck.de/wikifarm/fields/englishlanguage/field.php/PhoneticsandPhonology/JourneyAlongTheVocalTractPage2)

Laryngeal structures. Structures that are visible during endoscopic evaluation
include structures within and above the laryngeal vestibule. Structures within the
laryngeal vestibule include the aryepiglottic folds, ventricular (false) vocal folds, true
vocal folds, the anterior and posterior commissures of the glottis, laryngeal ventricle,
interarytenoid space, and trachea. The structures located above the laryngeal vestibule
include the epiglottis and other areas within the pharynx (throat).
The aryepiglottic folds extend between the arytenoids and epiglottis. The
ventricular vocal folds lie superior to the true vocal folds and inferior to the aryepiglottic
folds. The true vocal folds are located inferior to the ventricular folds and above the
trachea at the glottis. The glottis includes the true vocal folds and the anterior and
posterior commissures. The anterior commissure is the midline area of the glottis where
the vocal folds meet anteriorly and where they are attached to the thyroid cartilage. The
posterior commissure of the glottis lies anterior to the cricoid cartilage in between the
arytenoid cartilages. The laryngeal ventricle is the area between the ventricular and true
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vocal folds on either side and extends nearly their entire length. The interarytenoid space
is found between the arytenoid cartilages and posterior to the glottis. The trachea is
located just below the vocal folds and is visualized during vocal fold abduction
(opening).
The epiglottis is located adjacent to the tongue base and anterior and superior to
the laryngeal vestibule. Some areas within the pharynx that may also be visualized
during endoscopic evaluation include the tongue base and valleculae, which lie superior
to the laryngeal vestibule. (Figure 1.10).

Figure 1.10 Aerial posterior view of vocal folds
(From: Anatomy of the glottis. (n.d.). Retrieved January 27, 2019, from
http://www.aboutcancer.com/anatomy_glottis.gif)

Stroboscopic Assessment
Stroboscopic imaging of the vibratory function and appearance of the vocal folds
plays a central role in the assessment and treatment of vocal pathologies. The
effectiveness of laryngeal stroboscopy for investigation of the vibratory and nonvibratory
function of the larynx is well proven (Bless, Hirano & Feder, 1987; Patel, Dailey &
Bless, 2008). Videostroboscopy allows the clinician to record vocal fold patterns for
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visual inspection of laryngeal structure and function. Stroboscopy is a term used to
indicate a specific type of light used during visualization of the laryngeal area. Because it
is impossible for the naked eye to see the rapidly vibrating vocal folds, in stroboscopy,
brief flashes of light at a frequency just slightly less than the rate of vocal fold vibration
slow the perceived rate of movement patterns of the vocal folds to allow for assessment
(Faure & Muller, 1992).
Vocal fold parameters viewed with stroboscopy. Efforts to standardize
perceptual assessment of the vocal folds using videostroboscopy have resulted in rating
systems of vocal fold vibratory and nonvibratory parameters. The Voice-Vibratory
Assessment with Laryngeal Imaging (VALI) is one such rating form developed by
Poburka, Patel, and Bless (2016) (Figure 1.11). This assessment is used to create a more
reliable visuoperceptual evaluation of the videostroboscopic examination. VALI is an
updated version of the Stroboscopy Evaluation Rating Form (SERF) (Poburka, 1999;
Poburka & Bless, 1998). The parameters assessed using VALI include the following:
glottal closure, amplitude, mucosal wave, vertical level, nonvibrating portion,
supraglottic activity, free edge contour, regularity, phase symmetry, and phase contour
(Figures 1.12-1.21). Additionally, nonvibratory observations, which include erythema
(redness), edema (swelling), varices (vascularity), and mucus are rated according to a
rating system adapted from Hirano and Bless (1993) (Figure 1.22). During examination,
the clinician uses the following definitions and images of each parameter assessed
according to descriptions and images provided in the VALI rating form (Poburka et al.,
2016).
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Figure 1.11 VALI rating form for stroboscopy. Voice-Vibratory Assessment with Laryngeal Imaging
(VALI) -- Stroboscopy (Poburka, B., Patel, R., and Bless, D. 2016).
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Figure 1.11 (continued)
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Glottal closure. Glottal closure is the appearance of the glottis during the most
closed portion of the glottal cycle at normal pitch and loudness (Poburka et al., 2016).
The glottis is a term that defines the vocal folds and the space between them within the
larynx. Analysis of various closure patterns is helpful in diagnosing laryngeal pathology.
Glottal closure patterns assessed using VALI include: complete, anterior gap, posterior
gap, hourglass, spindle gap, irregular, and incomplete (Figure 1.12). Normal closure
patterns include complete closure and posterior gap. Abnormal glottal closure patterns
include anterior gap, hourglass closure, spindle gap, irregular closure, and incomplete
closure.
In the complete closure pattern, the vocal folds fully adduct without any glottic
spaces or gaps. In the posterior gap pattern, there is a small glottic gap, which is
triangular in appearance and located in the posterior aspects of the vocal folds. This
closure appears to be common in Caucasian and African American females more so than
males, but a study by Meeks (2017) suggested that posterior gap in African American and
Asian males may not be pathologic as well.
A small glottic gap exists anteriorly during vocal fold adduction in the anterior
gap closure pattern. This pattern can be indicative of vocal fold pathology, including
vocal nodules. In the hourglass pattern, the vocal fold closure occurs only at one point,
and is typically observed in the medial to anterior one-third of the vocal folds. There is no
adduction anterior or posterior to this point. The hourglass closure pattern is associated
with the presence of bilateral vocal nodules located at the point of vocal fold closure.
In the spindle gap closure pattern, the vocal folds adduct in both the anterior and
posterior aspects but bow outward from midline in the medial aspects leaving a glottic
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space. The spindle pattern is most commonly seen with hypofunctional dysphonia and
presbyphonia. In the irregular closure pattern, the vocal folds do not adduct along their
length and cannot complete closure during adduction due to irregular and rough margins.
The irregular pattern can be indicative of vocal fold pathology, including laryngeal
cancer. Incomplete closure is observed when the vocal fold margins are smooth in
appearance and the vocal folds do not fully adduct along the entire length. Incomplete
closure can indicate abnormality and hyperfunctional dysphonia.
In instances where the vocal folds show more than one pattern, the closure pattern
is termed “variable closure” (Poburka et al., 2016). Images for comparison are provided
on the rating form (Figure 1.12). Closure patterns are documented at low frequencies and
high frequencies for each participant.

Figure 1.12 Glottal Closure patterns
From VALI rating system (Poburka et al, 2016)

Amplitude. Poburka et al. (2016) define amplitude as the magnitude of lateral
movement of the vocal folds. In normal conditions, the point of contact of the lateral
movement of the vocal folds is one half the width of the visible portion of the vocal folds.
Increased vocal intensity or loudness will increase amplitude. Increased stiffness, mass,
and pitch will reduce amplitude. VALI uses a numerical rating system that rates
movement from 2-10 and corresponding images aid in documentation of the point of
contact of lateral movement (Figure 1.13). A rating of 2 is given with minimal lateral
separation of the vocal folds when voicing at normal pitch and loudness, indicating
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significantly reduced amplitude or intensity. A rating of 10 is maximal lateral separation
of the vocal folds, indicating maximum amplitude or intensity. Amplitude is reported
separately for the left and right vocal folds.

Figure 1.13 Amplitude rating system
From VALI rating system (Poburka et al, 2016)

Mucosal wave. Mucosal wave is the magnitude of movement of the mucosal
membrane (Poberka et al., 2016). During vocal fold vibration, the mucosal wave
originates on the medial surface of the vocal folds and moves laterally across the superior
surface of the mucosal cover, spreading bilaterally (Hirano & Bless, 1993). Any change
in the mucosal cover will alter the mucosal wave (Hirano, 1981). The movement of the
mucosal wave also provides information about the status of the tissue that is between the
cover and the vocalis muscle of the vocal folds.
If the vocal fold is stiff and resists movement or is edematous, this may reduce the
mucosal wave or cause it to be absent. As said, most lesions affect the cover, causing
restricted movement of the mucosal wave. Edema of the epithelium increases mass and
stiffness of the cover, which interferes with the vibratory function of the vocal folds, thus
also affecting the mucosal wave. Reinke’s Edema can make the vocal fold cover more
massive, less stiff, and more compliant, resulting in an altered mucosal wave.
Using videostroboscopy, the location of altered mucosal movement can often be
specifically noted. VALI uses a numerical rating system from 2-10 for movement of the

22

mucous membrane at normal pitch and loudness (Figure 1.14). A rating of 2 coincides
with minimal motion of the mucosal wave, and would indicate increased swelling,
stiffness, or otherwise restricted, nearly absent movement. A rating of 10 indicates
movement of the mucosal wave across the total visible width of the vocal folds. A rating
greater than 8 bilaterally indicates normal motion of the mucosal wave. Mucosal wave
will be rated separately for the left and right vocal folds.

Figure 1.14 Mucosal wave rating system
From VALI rating system (Poburka et al, 2016)\

Vertical level. Poberka et al. (2016) define vertical level as whether the vocal
folds meet on plane. If the vocal folds do not meet on plane, the form provides options
for description of off plane meeting, i.e., whether the left or right vocal fold is lower
(Figure 1.15). Structural abnormalities in one or more vocal folds can lead to
approximation of vocal folds off the vertical plane (Van den Berg, 1968).

23

Figure 1.15 Vertical Level rating system
From VALI rating system (Poburka et al, 2016)

Non-vibrating portion. Non-vibrating portion is defined by Poberka et al. (2016)
as adynamic segments of tissue that appears stiff. Stiff tissue is indicative of pathology,
including nodules, polyps, edema, or early signs of laryngeal carcinoma, which originates
in the mucosal cover. The gradual change in stiffness throughout the vocal fold structure
is an important histological component of healthy vocal folds (Hirano & Bless, 1993).
Stiffness gradually decreases from the stiff vocalis muscle to the pliable mucosal cover.
Any change in the stiffness of the tissue alters how the structures function.
The superficial layer of the vocal folds is where edema often develops (Hirano,
1981). Edema and lesions increase mass and stiffness, which interferes with vocal fold
vibration (Hirano, 1981). The VALI rating form shows vocal folds with 10 ovals on the
surface of each fold. Each oval accounts for 10% of the true vocal fold. The evaluator
shades in the ovals on the rating form that correspond to the area of stiffness or reduced
or absent movement observed during videostroboscopy (Figure 1.16).
24

Figure 1.16 Non-vibrating portion rating system
From VALI rating system (Poburka et al, 2016)

Supraglottic activity. Poburka et al. (2016) define supraglottic activity as
constriction of supraglottic structures during sustained phonation. Supraglottic structures
are those that lie above the true vocal folds and below the tongue base. These include the
ventricle, the ventricular folds, the epiglottis, the arytenoids, the laryngeal aspects of the
aryepiglottic folds, and the vestibule (Stager, 2011). Supraglottic activity may occur due
to vocal abuse or misuse, compensation of the larynx due to pathology, illness or injury,
and/or the type of endoscope used in assessment (Stager, Bielamowicz, Regnell, Gupta,
Barkmeier, 2000; Nospes, Kuhr, Napiontek & Keilmann, 2011). Two types of
supraglottic constriction or compression may be noted: static or dynamic. Static activity
initiates when phonation begins and remains until vocal fold vibration ceases. Dynamic
activity changes throughout speaking tasks. A subset of dynamic activity is the
occurrence of compression upon initiation of a speaking task (Stager, 2011).
Normal arytenoid movement is symmetrical during adduction and abduction.
Asymmetrical movement of the arytenoids as well as hyperfunction are noted by the
clinician. During phonation, the ventricular folds should vibrate minimally and be
relatively stationary and remain apart. Vocal hyperfunction refers to conditions of abuse
and/or misuse of the vocal mechanism due to excessive and/or imbalanced muscular
forces (Hillman, Holmberg, Perkell, Walsh & Vaughan, 1989). Anterior-posterior and
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mediolateral ventricular fold compression are rated from 0-5 (Figure 1.17). A rating of 0
indicating normal supraglottic activity and 5 indicating maximal abnormal supraglottic
activity.

Figure 1.17 Supraglottic activity rating system
From VALI rating system (Poburka et al, 2016)

Free edge contour. Poberka et al. (2016) define free edge contour as the
smoothness and/or straightness of free edge of the vocal folds. Evaluators are instructed
to rate right and left vocal folds individually during abduction. Descriptions of free edge,
which are accompanied by a corresponding image on the VALI rating form, include
normal, convex, concave, irregular, and rough (Figure 1.18). Abnormal vocal fold edge
may be due to histological alteration following chronic irritation or edema. Edematous
vocal folds may have a convex appearance, whereas thinning vocal folds may have a
concave appearance. Irritated vocal folds or those with lesions or other histological
alterations may present with an irregular or rough appearance.

Figure 1.18 Free Edge Contour rating system
From VALI rating system (Poburka et al, 2016)
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Phase closure. Phase closure is defined by Poberka et al. (2016) as the relative
durations of appearance of consecutive glottal cycles. A glottal cycle consists of one open
phase and one closed phase. In normal symmetrical phase patterns, the timing of the open
phase and closed phase is almost equal. Symmetrical phase closure indicates that the
folds have similar mechanical properties. When vocal quality is breathy or weak, as with
hypoadduction or when lesions or bowing interfere with vocal fold closure, the open
phase predominates. When vocal quality is harsh or strangled as with hyperadduction, the
closed phase predominates.
VALI provides a continuum for rating phase closure. The clinician marks the
point on the continuum where phase closure resides. The continuum includes three
descriptions: phase closure when open phase predominates, phase closure when the
phases are nearly equal, and phase closure when closed phase predominates. For phase
closure that falls between two descriptions, the clinician identifies the appropriate point
on the continuum, e.g., between nearly equal phase closure and when closed phase
predominates. Phase closure is rated at the point of contact of the vocal folds (Figure
1.19).

Figure 1.19 Phase Closure rating system
From VALI rating system (Poburka et al, 2016)
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Phase Symmetry. Phase symmetry is defined as the degree to which the vocal
folds move as mirror-opposite images of each other, or 180° phase difference (Poburka et
al., 2016). In normal symmetrical phase patterns, the bilateral vocal fold movement is
almost equal. Symmetry in phase indicates that the vocal folds have similar mechanical
properties. The evaluator selects the percentage of exam time where the vibration is
symmetrical. The form provides a visual description of asymmetry and symmetry (Figure
1.20). Phase asymmetry is indicative of unilateral changes in vocal fold tissue, e.g.,
lesions and edema.

Figure 1.20 Phase Symmetry rating system
From VALI rating system (Poburka et al, 2016)

Regularity. Regularity is defined as the consistency of cycles or the type of phase
closure observed (Poburka et al., 2016). The evaluator indicates the percentage of the
exam that vibration is regular, from always regular to never regular. Lack of regularity in
phase closure is indicative of vocal pathology, such as the presence of lesions or swollen
tissue. This portion of the rating form includes images depicting regularity and
irregularity (Figure 1.21).

Figure 1.21 Regularity rating system
From VALI rating system (Poburka et al, 2016)
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Nonvibratory observations. Poburka et al. defined nonvibratory observations as
the structural observations not mentioned elsewhere. These include structural differences,
such as asymmetry, erythema, vascularity, and mucus. Erythema refers to redness of the
vocal folds and laryngeal structures. The presence of erythema is indicative of irritation,
dehydration, and/or trauma of the tissue. Observations may involve the interarytenoid
space, arytenoids, aryepiglottic folds, ventricular folds, ventricle, and epiglottis.
Subjective evaluation of nonvibratory observations is rated from “within normal limits”
or “none” to “severe” (Hirano & Bless, 1993) (Figure 1.23).
Parameters

VF

Rating

Vocal fold (VF)
varices

right

0 = wnl

1 = mild

2 = moderate

3 = severe

left

0 = wnl

1 = mild

2 = moderate

3 = severe

VF edema

right

0 = no edema

1 = mild

2 = moderate

3 = severe

left

0 = no edema

1 = mild

2 = moderate

3 = severe

right

0 = pearl white
appearance

1 = mild

2 = moderate

3 = profound

left

0 = pearl white
appearance

1 = mild

2 = moderate

3 = profound

right

0 = wnl

1 = mildly
thick/thin and
clear

2 = moderately
thick/thin and
mildly opaque

3 = severely
thick/thin and
moderately
opaque

left

0 = wnl

1 = mild

2 = moderate

3 = severe

Ventricular fold
erythema

right

0 = wnl

1 = mild

2 = moderate

3 = severe

left

0 = wnl

1 = mild

2 = moderate

3 = severe

Arytenoid
Erythema

right

0 = wnl

1 = mild

2 = moderate

3 = severe

left

0 = wnl

1 = mild

2 = moderate

3 = severe

Arytenoid
edema

right

0 = wnl

1 = mild

2 = moderate

3 = severe

left

0 = wnl

1 = mild

2 = moderate

3 = severe

VF
discoloration

VF mucus

*wnl = within normal limits
Figure 1.22 Nonvibratory observations rating form (adapted from Hirano & Bless, 1993).
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Acoustic Analysis
Acoustic parameters provide objective and noninvasive measures of the function
of laryngeal anatomy. These measures are successful at monitoring changes in voice
quality over time. Among the vocal parameters assessed are Fundamental Frequency (F0)
and perturbation measures, including jitter and shimmer. Acoustic analysis software
allows the clinician to record vocal productions for perceptual analysis and provides
graphic imaging and statistical analysis of acoustic measurements.
F0 provides information on the mass and stiffness of the vocal folds. F0 is the
acoustic correlate of pitch, or the perceived rate of vocal fold vibration. As F0 changes,
the listener perceives a change in pitch. F0 refers to the frequency that occurs most often
during phonation. It is the number of vocal fold phases (openings and closings) that occur
in one second, as measured in Hertz (Hz) or cycles per second. A typical adult male will
have a F0 between 85 and 155 Hertz, while an adult female will have a F0 between 165 to
255 Hertz. The norm for females ages 18-39 is 214.39 (SD 26.76), and the norm for
males ages 18-39 is 106.41 (SD 13.29) (Shaefer et al., 2008). F0 is determined by length,
tension, and mass of the vocal folds (Boone et al., 2011).
Vocal perturbation measures include jitter and shimmer. Vocal perturbation refers
to small changes in the vocal system. Perturbation measures provide strong measures of
the basic perceptual elements of voice quality (Wolfe, Finch & Martin, 1997). Jitter refers
to the abnormalities or variation in cycle-to-cycle signal frequency, which relates to pitch.
The norm for males ages 18-39 for jitter is 1.41% (SD 0.32%) (Shaefer et al., 2008). The
norm for females ages 18-39 for jitter is 0.82% (SD 0.28%) (Shaefer et al., 2008).
Shimmer refers to the abnormalities in the amplitude of vocal fold vibration, which
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relates to intensity or loudness. The norm for males for shimmer is 2.14% (SD 0.32%)
and the norm for females for shimmer is 1.59% (SD 0.68%) (Shaefer et al., 2008).
Raised jitter and/or shimmer values may be indicative of changes that have occurred in
the structure of the laryngeal epithelium and is a probable indicator for a physiological
disorder (Wolfe, Cornell & Palmer, 1991; Hirano & Bless, 1993; Lourenco, Costa, &
Filho, 2014).
Literature Review
A limited number of studies citing the long-term health effects of ENDS are
available. This is likely due to the recent availability of ENDS products on the global
market as well as a lack of regulations and standards governing ENDS production.
Reports of adverse effects have included complaints of throat symptoms, including
irritation of the throat during ENDS inhalation (Polosa et al., 2014). Additionally, similar
types and levels of toxins to those in cigarette smoke have been found in ENDS aerosols.
Despite evidence that ENDS may have an effect on the laryngeal structures, to the best of
this clinician’s knowledge, to date, no human studies and only one animal study on the
effect of ENDS on the larynx has been published.
A study conducted by Salturk et al. (2015) assessed the effects of ENDS on the
laryngeal mucosa of rats, with an additional focus on comparing effects of convection
heat of ENDS aerosol to combustion heat produced by cigarette smoke on the larynx.
This study assessed the histopathologic effects of ENDS on the vocal fold mucosa of 16
rats after exposure for 60 minutes per day for four weeks to ENDS with 0.9% (wt/vol) or
9 mg/ml nicotine. Rats were exposed to ENDS aerosol within a smoke drum, which
contained two holes: one for inspiration and one for expiration. With the ENDS device
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placed in the inspiration hole, 200 mL/minute of aerosol entered the drum and was fully
distributed within 20 minutes. At the end of four weeks, the rats were sacrificed, and each
vocal fold was removed and examined histologically. Salturk et al (2015) found that
ENDS may have effects on the vocal fold epithelium. The study found that epithelial
responses, which included hyperplasia (increase in cell number) and metaplasia (change
in cell type), were evident though not found to be significant.
Some gaps in this study by Salturk et al (2015) include the fact that exposure was
a controlled application, which does not mirror use in humans. Humans typically use
ENDS in approximately 5-minute intervals or sessions, consistent with cigarette use,
and/or take single puffs frequently, potentially 100s of times, throughout the day. ENDS
users puff deeply and directly from a device, hold the material briefly in the lungs and
then exhale, rather than inhaling aerosol that is distributed through the air during patterns
of normal respiration. The nicotine solution used in this study was 0.9% wt/vol. or (9
mg/ml), which is not representative of the wide range of nicotine levels that are currently
consumed by human beings, e.g., Juul, which has 59 mg/ml. Additionally, the study did
not list the battery voltage or e-liquid contents used to create the aerosol, which have
been shown to alter the toxicity of ENDS aerosol (Kosmider et al., 2014; Rowell &
Taran, 2015). Finally, this study was limited to four weeks duration and was also limited
in the number of participants included.
While studies on the effects of ENDS on the larynx are limited to one, the effect
of cigarette smoke is well studied. Reported histologic changes in the larynx in relation to
smoking include atypical microscopic changes in the true vocal fold, false vocal folds,
and the area above and below the level of the vocal folds, including epithelial hyperplasia
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and metaplasia (Auerbach et al., 1970; Levendoski, Leydon, & Thibeault, 2014; Gaafar
& Al-Monsour, 1981). Smoking has been found to cause Reinke’s edema, chronic
laryngitis, and diffuse vocal fold polyps as well as triggering reflux that affects the
larynx, termed laryngopharyngeal reflux (Öğüt & Kiliç, 2013; Stanciu & Bennett, 1972).
Smoking leads to chronic irritation and can lead to an increase in vocal fold mass and
thickening of vocal fold epithelium, as well as carcinomas in the epithelium (Kelleher, et
al., 2014). Auerbach et al. (1970) found that effects of cigarette smoke on laryngeal
epithelium were similar to previous findings of histologic change on bronchial
epithelium. Similarly, studies have shown negative effects of ENDS on bronchial
epithelium (Lerner et al., 2015), which further studies may find to be similar in laryngeal
epithelium of ENDS users. Additionally, studies on the toxicity of ENDS reveal similar
toxins to those found in cigarette smoke and, with sufficient battery output, ENDS
aerosol has been shown to contain toxins at similar levels as well.
A study by Awan and Morrow (2007) compared the laryngeal characteristics of
young adult female smokers versus nonsmokers using videostroboscopy. The goal of this
study was to observe any early effects of smoking on the laryngeal structures and
phonatory function. Participants included 34 nonsmoking females and 30 smoking
females between the ages of 18 and 30 years old. Nonsmokers were operationally defined
as participants who did not smoke and had not smoked for at least 5 years before the time
of the study. Smokers were operationally defined as individuals who had smoked at least
two cigarettes per day for at least one year. This study found a significant relationship
between smoking and edema, erythema, and discoloration of laryngeal structures. It also
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found a significant relationship between abnormal phase symmetry and increased glottal
gap size during the closed phase of phonation (Awan & Morrow, 2007).
A study conducted by Banjara, Mungutwar, Singh, and Gupta (2011) compared
the larynges of smokers with that of non-smokers using videostroboscopy and acoustic
voice analysis to determine the effects of smoking on the laryngeal anatomy and vocal
physiology of smokers. The study’s findings supported prior research that shows cigarette
smoke has a significant impact on the larynx (Myerson, 1964; Auerbach, Hammond, &
Garfinkel, 1970; Awan & Morrow; 2007; Banjara et al., 2011; Kelleher et al., 2014; Öğüt
& Kiliç, 2013; Stanciu & Bennett, 1972).
A sampling of 50 male smokers and 50 male nonsmokers between the ages of 18
and 60 years participated in the study. Smokers were defined as any participant who, at
the time of the study, had smoked at least two cigarettes per day for at least one year.
Nonsmokers were defined as those who, at the time of the study, did not smoke and who
had not smoked for five years before the study.
The researchers rated various aspects of the vocal folds as visualized on
videostroboscopy using a rating system described by Hirano and Bless (1993). A
criterion level of at least two judge agreements was required for a particular rating to be
documented. Additionally, acoustic voice analysis and EGG measures were completed
using Electroglottography. Acoustic analysis included the following parameters:
fundamental frequency, frequency perturbation (shimmer), amplitude perturbation (jitter),
F0 tremor, normalized noise energy (NNE), harmonic-noise ratio (HNR), signal-noise
ratio (SNR), amplitude tremor, maximum phonation time (MPT), and S/Z ratio. The
following EGG parameters were evaluated: fundamental frequency, EGG-Jitter, EGG-
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Shimmer, EGG F0 tremor, contact quotient (CQ), contact index (CI), CQ perturbation, CI
perturbation, opening rate and closing rate.
Banjara et al (2011) found a significant relationship between smoking and
abnormal vocal fold edge, abnormal texture, edema, erythema, abnormal mucosal cover,
abnormal phase symmetry and abnormal pliability/stiffness. Abnormal vocal fold edge in
smokers included primarily swollen and rough vocal edge. These researchers found that
the most common texture differences between smokers and non-smokers were mild to
moderate roughness in smokers. This study also observed a highly significant relationship
between the presence of edema and smoking as well as a significant relationship between
increased erythema and smoking.
Banjara et al. (2011) observed a significant difference in abnormal mucosal cover
in smokers as compared to nonsmokers. The most common mucosal cover abnormality
observed in smokers was thick mucosal cover, which the study suggested was likely a
result of the vocal folds chronic inflammatory response to cigarette smoke.
Banjara et al. (2011) observed a significant difference in abnormal phase
symmetry in smokers as compared with nonsmokers. The most common abnormal phase
symmetry observed in conventional smokers was asymmetrical phase symmetry (Banjara
et al., 2011). Banjara et al. (2011) observed a significant relationship between changes in
stiffness/pliability and smoking. Specifically, the study found mild to moderate stiffness
in smokers. Researchers suggested this increase in stiffness was likely the result of longstanding edema caused by smoking. The study suggested that studies with younger
participants may not see a significant relationship between smoking and stiffness due to
long-standing edema occurring only after long term use.
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The most common glottal closure patterns observed in the study were spindle gap
and irregular glottal closure patterns; however, no significant difference was observed
between abnormal glottal closure pattern findings.
Results of acoustic analysis in this study showed decreased values of F0,
significantly higher values of perturbation measures (jitter and shimmer), and
significantly increased F0 tremor (Banjara et al., 2011). These findings are consistent with
other studies on the acoustic measures of cigarette smokers (Damborenea et al., 1999).
The study also found raised values of NNE in smokers as compared to non-smokers, as
well as lower values of SNR, and lower values of MPT. Finally, raised values of s/z ratio
were discovered in smokers as compared to non-smokers in this study.
An important gap in this study by Banjara et al. (2011) as well as the study by
Awan and Morrow (2007) is that while these studies provide a detailed analysis of
cigarette smokers as compared to non-smokers, they do not compare smokers and nonsmokers with ENDS users. ENDS use is rapidly increasing. ENDS are used by former
smokers for tobacco cessation and by nonsmokers as the initial form of nicotine use
(Kaisar et al., 2016). As ENDS are commonly used by both smokers and nonsmokers,
comparing the laryngeal anatomy and physiology of ENDS users to smokers and
nonsmokers is necessary and has the potential to provide valuable insight into the effects
of ENDS on the larynx.
The purpose of the present study is to investigate the visual appearance and
acoustic measures of the vocal folds and laryngeal structures of ENDS users as compared
to smokers and nonsmokers. Because ENDS aerosol is inhaled in a similar manner and
may contain similar types and levels of toxins as are present in cigarette smoke, it is
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likely that ENDS may have a similar effect on laryngeal anatomy and physiology. First,
this study aims to discover whether acoustic analysis will reveal similarities in acoustic
measures of ENDS users and smokers. It is hypothesized that ENDS users and smokers
will experience a similar reduction in F0 and a similar increase in perturbation measures.
Second, this investigation aims to determine whether there are similarities in the mucosal
wave and vibratory characteristics of ENDS users as compared to smokers. It is
hypothesized that ENDS users and smokers will present with similarities in vibratory
characteristics, including mucosal wave movement. Third, this study aims to investigate
whether there are similarities in the visual appearance of the vocal folds of ENDS users
as compared to smokers. It is hypothesized that the vocal folds of ENDS users will have a
similar visual appearance to that of smokers. Finally, this investigation aims to discover
whether similarities exist in the visual appearance of laryngeal structures of ENDS users
and smokers. It is hypothesized that the laryngeal structures of ENDS users will have a
similar visual appearance to that of smokers.
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CHAPTER II
METHODS

The investigation, materials, and procedures for this study were approved by the
Institutional Review Board (IRB) of Cleveland State University. This investigator
recruited, screened, and collected data for all participants. All data were collected in the
voice lab of the Cleveland State University Speech and Hearing Clinic. Informed consent
was obtained from each participant after receiving a detailed explanation of the nature of
the study (Appendix A).
A total of 20 healthy individuals participated in this study. Participants included 7
ENDS users and 4 cigarette smokers. A control group of 6 non-smokers was also
included in this study. Participants’ ages ranged from 18 to 35 years old, with an average
of 28.14 (SD 7.10) years for ENDS users, an average of 30 (SD 2.45) years for smokers,
and an average of 27.88 (SD 5.12) years for non-smokers. As far as possible, participants
in each group were matched closely for age and gender. Table I lists the participants’
characteristics in terms of age, gender, and grouping. Participants were recruited via
word of mouth and flyers through the student investigator. The student investigator
provided monetary compensation to those willing to participate and to those who helped
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to locate participants. Participation in this study included one sixty-minute session
at Cleveland State University’s voice lab located at the Center for Innovation in Medical
Professions (CIMP). The entire period of data collection combined for all participants
was approximately three months.
To meet the inclusionary criteria, participants had to be between 18 and 35 years old.
Race was not a factor. Gender was only a factor in the investigator’s attempts to match
participants of a particular gender between groups. Based on their own personal account,
participants were screened for conditions and daily habits known to cause visible changes
in laryngeal anatomy and physiology, as well as changes in pitch and perturbation
measures. All participants completed a questionnaire prior to data collection for the
purpose of screening these areas (Appendix B). ENDS users and cigarette smokers were
asked to use their devices or smoke within 15 minutes prior to data collection to
minimize the variable of time since last use. All tasks were completed within the same
visit using identical instructions (Appendix C and D), physical positioning, endoscope,
and equipment.
For the purposes of this study, ENDS users were defined as individuals with daily
ENDS use for at least one year and no cigarette use for at least 5 years prior to data
collection. Smokers were defined as individuals with daily cigarette use of at least two
cigarettes per day for at least one year with no prior ENDS use by the time of data
collection. Nonsmokers were defined as individuals with no cigarette use for at least 5
years prior to data collection, and no history of ENDS use. Exclusionary criteria
included: any diagnosis of a vocal fold pathology or GERD at the time of data collection,
respiratory/sinus infections affecting laryngeal health within two weeks of data
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collection, a history of chronic overuse/abuse of the voice, and/or an overactive gag
reflex.
Gender

Mean Age

Group
Female

Male

Age (years)

SD

ENDS

2

5

28.14

7.10

Smokers

2

2

30.00

2.45

Nonsmokers

4

2

27.88

5.12

Table I: Gender and mean age by group

Acoustic Analysis
Acoustic analysis provides information on the function of the laryngeal anatomy
and an objective measure of the vibratory characteristics and patterns of the vocal folds
and laryngeal structures (Hirano & Bless, 1993). Abnormal acoustic measurements are
indicative of vocal fold pathologies. The voice parameters assessed in acoustic analysis
included F0, and vocal perturbation measures, including jitter and shimmer.
Quantitative measures were collected on each participant using the Kaypentax
Visi-pitch IV. This is a clinical instrumentation tool used by speech-language pathologists
for assessment, treatment, and research purposes. It provides auditory and visual
feedback as well as objective data for measuring fundamental frequency, perturbation
measures and other acoustic information. Abnormalities within these measures reflect
dysphonia or dysfunction, and may be indicative of vocal pathologies (Lourenco, Costa,
& Filho, 2014). The microphone was placed two inches from the participants’ mouth
while the participant sustained the vowel /a/ in a natural voice for at least five seconds
according to given instructions (Appendix C).
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Videostroboscopy
Videostroboscopy is used frequently by speech-language pathologists and
otolaryngologists in assessment and treatment of vocal fold and laryngeal pathologies.
KayPentax 70-degree Rigid StrobolaryngoscopeTM model 9106 was used to complete a
videostroboscopic assessment of the vocal folds of each participant. Topical anesthesia
was not used for any of the participants. In this study, videostroboscopy was used to
visualize and describe the laryngeal area of participating individuals.
The endoscope used in this study is a standard strobolaryngoscope, with mounted
camera and microphone attachment. The tip of the scope contains a fiberoptic strobe light
for observation of the mucosal wave. A rigid endoscope was placed just beyond the
tongue base while the participant vocalized according to given instruction (Appendix D).
Vocal patterns were recorded and saved on an audiovisual recording on the KayPentax
equipment for further review of laryngeal structures and function. This investigator
directly observed and reviewed participant’s laryngeal structures and function according
to the VALI rating form (Poberka et al., 2016). A criterion level of two judge agreements
was required for a particular rating to be documented. The principal-investigator and
student-investigator served as judges for this study. The principal-investigator is a
licensed speech-language pathologist and the student-investigator is a second-year
graduate student in speech-language pathology.
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Questionnaire
Each participant completed a questionnaire prior to administration of instrumental
evaluations (Appendix B). The questionnaire included screening questions used to assess
whether participants met inclusionary criteria to be part of this study. The questionnaire
also included questions regarding vocal habits and any known vocal pathologies. In
addition, participants answered questions detailing ENDS or cigarette use. ENDS users
provided information regarding device used, length of use, flavors of e-liquid, frequency
of use, and factors that contributed to initial/current ENDS use. Each questionnaire is
identical for all participants, regardless of use or lack of use of ENDS or cigarettes.
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CHAPTER III
RESULTS

This study investigated the appearance and function of the vocal folds and
laryngeal structures of ENDS users as compared to smokers and nonsmokers using
videostroboscopic and acoustic analysis. Acoustic analysis included 3 sets of variables:
fundamental frequency, jitter percent, and shimmer percent. The results of acoustic data
were assessed using SPSS Statistics 24 (IBM, Armonk, NY). Data collected were rated in
comparison between groups, as well as to established norms for age and gender (Schaefer
et al., 2008).
The results of videostroboscopic data were analyzed in a descriptive manner
according to the VALI rating form (Poberka et al., 2016). Information gathered was then
coded numerically in order to obtain data for comparison as described by Poburka et al.
(2016). For example, for free edge contour, a rating of “normal” was coded as 1,
“convex” was coded as 2, and so on, without these numbers otherwise containing any
descriptive value. Additional observations noted on the VALI form, including
discoloration, edema, erythema, and vascularity were rated from “within normal limits”
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to severe using a code described by Hirano and Bless (1993). For example, no
abnormal presence of vocal fold edema was rated 0, mild edema was rated 1, moderate
edema was rated 2, and severe edema was rated 3. Information gathered from acoustic
analysis and videostroboscopy was assessed using SPSS Statistics 24 (IBM, Armonk,
NY). Videostroboscopic findings were then compared to acoustic data. The results of the
self-assessment of ENDS users were used to assess whether any correlations could be
made between self-assessment responses and findings from endoscopic and/or acoustic
evaluation.
Acoustic Results
A one-way between subjects analysis of variance (ANOVA) was conducted to
compare the effect of the nicotine device used, including ENDS, cigarettes, or non-use,
on three acoustic measures: fundamental frequency, shimmer percent, and jitter percent.
Fundamental frequency was assessed separately for male and female participants across
the three groups (Tables II and III). Shimmer percent obtained from participants of both
genders was compared across groups (Table IV). Jitter percent obtained from participants
of both genders was also compared across groups (Table V). Finally, the number and
percentage of ENDS users and smokers with normal and abnormal acoustic measures was
presented in a table for comparison across groups (Table VI). All acoustic measures were
collected at normal loudness and comfort level via Visi-pitch IV. The results are as
follows:
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Table II: Fundamental frequency measures using ANOVA among female ENDS users, smokers and nonsmokers.

Table III: Fundamental frequency measures using ANOVA among male ENDS users, smokers and nonsmokers.

Table IV: Shimmer Percent measures using ANOVA among all ENDS users, smokers and non-smokers.

Table V: Jitter Percent measures using ANOVA among all ENDS users, smokers and non-smokers.
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Table VI: Number and percentage of acoustic parameters rated as “normal” or “abnormal” compared to
norms for age and gender for ENDS and smoker groups.
Rated
Characteristic

ENDS

Smokers

Normal

Abnormal

Normal

Abnormal

Fundamental
Frequency

7 (100%)

0 (0%)

3 (75%)

1 (25%)

Jitter Percent

5 (71%)

2 (29%)

2 (50%)

2 (50%)

Shimmer
Percent

2 (29%)

5 (71%)

0 (0%)

4 (100%)

Comparison with norms for males and female nonsmokers, ages 18-39 years (Schaefer et al., 2008).
*Normal = within one SD of the mean; Abnormal = outside of one SD of the mean.

No significant difference was observed between groups for any of the
aforementioned acoustic parameters (significant at P < 0.05; marginally significant at P <
0.09) using ANOVA. Marginal significance is commonly used to describe data obtained
from a small sample size. This indicates a pattern to be explored in future research. When
compared to norms for nonsmokers of similar age and same gender, fundamental
frequency and jitter percent values for ENDS users and smokers in the present study were
comparable to norms (Schaefer et al., 2008); however, comparison revealed abnormal
shimmer percent in a majority of ENDS users as well as smokers when compared to
norms for nonsmokers (Appendix E).
Videostroboscopy Results
A one-way between subjects ANOVA was performed on data obtained using the
VALI rating form and numerical coding of responses. The following areas were rated
using VALI: glottal closure, amplitude, mucosal wave, vertical level, non-vibrating
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portion, supraglottic activity, free edge contour, phase closure, phase symmetry, and
regularity. Non-vibrating portion was difficult to assess due to increased supraglottic
activity in many participants. It was therefore removed from the list of parameters
assessed in this study. Nonvibratory characteristics, which are a parameter assessed on
VALI and distinct from non-vibrating portion, were noted on the VALI form during and
after completion of videostroboscopy upon review of recorded video. Information
gathered for each participant was then coded numerically for assessment using a one-way
between subjects ANOVA.
ANOVA determined significant interactions between means of data collected
using the VALI rating form (Table VII) and between means of data collected from
descriptions of nonvibratory characteristics (Table IX). A Tukey Post Hoc test was then
used to determine which relationships between the three groups were significant in the
aforementioned areas (Tables VIII and X).
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Table VII: ANOVA comparison of videostroboscopic parameters among ENDS users, smokers, and nonsmokers assessed using VALI rating form (Poberka et al., 2016).
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Table VIII: Tukey multiple comparison of videostroboscopic parameters with significant relationships on
ANOVA among ENDS users, smokers, and non-smokers assessed using VALI rating form (Poberka et al.,
2016).

Abnormal mucosal wave, free edge, and phase closure show significant
relationships in ENDS users as compared to nonsmokers (significant at P < 0.05).
Reduction in mucosal wave was consistently noted to occur in the presence of increased
edema and observed thick mucosal cover (Figure 3.1). Abnormalities in free edge were
most commonly convex or irregular (Figure 3.2). Close phase predominating was the
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most frequently occurring form of abnormal phase closure noted in ENDS users and was
also consistently noted with the observed presence of edema. Abnormal phase symmetry
and regularity show a marginally significant relationship in ENDS users as compared to
nonsmokers (marginally significant at P < 0.09) (Figure 3.3), and again consistently
noted with the observed presence of edema.

Figure 3.1: Increased edema and thick mucosal cover of ENDS users resulting in a reduction in mucosal
wave (left and middle); vocal folds of nonsmoker with normal mucosal wave (right).

Figure 3.2: Irregular (left), convex (middle) abnormalities in free edge contour of ENDS users; normal free
edge contour of nonsmoker (right)

Figure 3.3: Abnormal phase symmetry in ENDS user

Abnormal phase closure also shows a significant relationship in smokers as
compared to nonsmokers. Abnormal mucosal wave and phase symmetry shows a
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marginally significant relationship in smokers as compared to nonsmokers. Abnormal
free edge was evident though not significant in smokers. No significant relationship was
observed for glottal closure, amplitude, supraglottic activity, and vertical level; however,
a pattern of abnormal supraglottic activity was evident in ENDS users as well as smokers
(see Figure 3.4).

Figure 3.4: Abnormal supraglottic activity (top row) in ENDS users (left and middle) and smoker (right)
and normal supraglottic activity (bottom row) in nonsmokers (left and middle) and ENDS user (right).
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Table IX: ANOVA comparison of nonvibratory observations among ENDS users, smokers, and nonsmokers subjectively assessed according to a rating system adapted from Hirano and Bless (1993) (see
Figure 1.22)
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Table X: Tukey multiple comparison of nonvibratory observations with significant relationships on
ANOVA among ENDS users, smokers, and non-smokers subjectively assessed according to a rating system
adapted from Hirano and Bless (1993) (see Figure 1.22).

ANOVA revealed significant relationships between groups and abnormal vocal
fold varices, vocal fold edema, vocal fold discoloration, and ventricular fold erythema
(Table IX). A Post-Hoc Tukey analysis revealed which relationships were significant
(Table X): Abnormal varices is characterized by capillary dilation or leakage. Abnormal
varices showed a significant relationship in both smokers and ENDS users when
compared to the nonsmoker group (Figure 3.5). Abnormal vocal fold edema is
characterized by unilateral or bilateral inflammation in the superficial layer of the vocal
folds, including Reinke’s space (see Figure 1.7). Abnormal vocal fold edema showed a
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highly significant relationship in ENDS users as compared to nonsmokers (highly
significant at P < .001). Abnormal vocal fold edema showed a significant relationship in
smokers as compared to nonsmokers (Figure 3.6).

Figure 3.5: Vocal fold vascularity in smoker (left) and no vocal fold vascularity in nonsmoker (right)

Figure 3.6: Unilateral edema of reinke’s space in ENDS user vibrating upon inhalation (left); no abnormal
edema in nonsmoker (right)

Vocal fold discoloration is noted when vocal folds have a yellow or pink
appearance, rather than the pearl-white appearance characteristic of healthy vocal folds.
A significant relationship was noted between vocal fold discoloration and cigarette use
when compared to the nonsmoker group, while a relationship was evident though not
significant between vocal fold discoloration and ENDS use (Figure 3.7).
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Ventricular fold erythema is characterized by reddening of the tissue due to
irritation. A marginally significant relationship was found between abnormal ventricular
fold erythema and smokers when compared to nonsmokers (Figure 3.8); however no
significant relationship was found between abnormal ventricular fold erythema and
ENDS use. Additionally, no significant relationship was observed for abnormal arytenoid
erythema, arytenoid edema, and vocal fold mucus between both ENDS users and smokers
as compared to nonsmokers; however, a pattern of thick, white mucus was observed on
the vocal folds of three of seven ENDS users, which was not observed on the vocal folds
of smokers and nonsmokers (Figure 3.9).

Figure 3.7: Yellowed appearance of vocal folds of ENDS user (left), reddened appearance of vocal folds of
smoker (middle), and pearl white appearance of vocal folds of nonsmoker (right).

Figure 3.8: Severe ventricular fold erythema in smoker (left); moderate to severe ventricular fold erythema
in ENDS user (middle); and no abnormal erythema in nonsmoker (right)

55

Figure 3.9: thick, white mucus of ENDS user (left); thin, clear mucus of nonsmoker (right)

Questionnaire Results
All responses provided by ENDS participants on a general questionnaire were
recorded and entered into a table for comparison (Table XI). Participants reported their
age, device used, duration of use in years, flavors used, frequency of use (in times per
day), and contributing factors in their decision to begin and continue using ENDS.
According to ENDS user responses provided on the general questionnaire,
participants used ENDS for an average duration of 3.64 (SD 2.06) years. Those who
reported using ENDS because they are trendy had used ENDS for three years or less.
Five of seven participants report using ENDS because they believe it is a safer nicotine
alternative to smoking cigarettes. Of seven total ENDS users, three reported using sweet
flavored e-liquids, three reported using menthol or mint flavored e-liquids, and one
reported using tobacco flavored e-liquids. Five of seven ENDS users report using 3rd or
current generation devices. Finally, five of seven ENDS users report using ENDS greater
than 20 times (sessions) throughout the day.
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Table XI: ENDS users’ individual questionnaire responses
Age
(years)

Device*

length of
use
(years)

Flavor

Frequency**

Factors

32

1,2

5

sweet

>20x/day

safer

31

3

6

tobacco

>20x/day

safer; indoor
use

35

3

3

sweet

>20x/day

safer; flavors

19

4

1

menthol

3-10x/day

safer; trendy

35

3,4

6

sweet

10-20x/day

safer; flavors

25

1

1.5

menthol

>20x/day

trendy

18

4

3

menthol

>20x/day

trendy

*Devices: 1 = first generation, 2 = second generation, 3 = third generation, 4 = current generation
**Frequency: Sessions (x)= five minutes or less of ENDS use.
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CHAPTER IV
DISCUSSION

Research Question 1: Are there similarities between acoustic measures of ENDS users
and smokers?
Results indicated that no significant relation was observed between acoustic
measures obtained from smokers and ENDS users; however, due to small sample size,
findings were also compared to norms for age and gender. When acoustic measures of
smokers and ENDS users were compared to norms, results revealed similarities in one
acoustic measure of ENDS users and smokers. Both showed raised shimmer percent in a
majority of participants. Increased shimmer percent is indicative of vocal pathologies,
such as altered tissue due to chronic irritation. This finding is consistent with prior
research on acoustic measures in smokers (Banjara et al., 2011; Damborenea et al., 1999).
Irritation and epithelial changes resulting from exposure to irritants and cytotoxic
compounds may be responsible for the observed increase in shimmer percent in ENDS
users (Buron et al., 2009; U.S. EPA, 2003; Arts et al., 2004; Farsalinos et al., 2013;
Rowell & Taran, 2015).
When compared to norms, no notable difference was observed in fundamental
frequency and jitter values. This finding is not consistent with prior research on acoustic
measures in smokers (Banjara et al., 2011; Damborenea et al., 1999). Fundamental
frequency changes due to smoking are attributed to increased mass due to swelling and
are most frequently observed in females rather than males (Banjara et al., 2011;
Damborenea et al., 1999; Gilbert & Weismer, 1974). This is likely due to females having
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a smaller range of what is perceptually “normal” pitch as compared to males. It is likely
that the female sample size in both the ENDS and smoker groups in the present study was
too limited to accurately investigate whether a comparison exists with regard to a
reduction in F0.
Research Question 2: Are there similarities in the vibratory characteristics, including
mucosal wave, of ENDS users as compared to smokers?
Results indicate that there are similarities in the mucosal wave and vocal fold
vibratory characteristics of ENDS users and cigarette smokers. In the present study, a
significant relationship was found between abnormal mucosal wave and ENDS use. A
marginally significant relationship was also found between abnormal wave and cigarette
smoking. As the mucosal wave is caused by movement of the mucosal cover and may be
reduced when the mucosal cover is altered, this finding appears to be consistent with
prior studies that have found thickened mucosal cover in smokers (Banjara et al., 2011).
It is speculated that abnormal mucosal wave in ENDS users in the present study may be
due to similar changes in mucosal cover caused by chronic irritation due to inhalation of
ENDS aerosol.
Abnormal phase closure showed a significant relationship in both ENDS users
and smokers as compared to nonsmokers in the present study. Among abnormal phase
closure, the most common form noted in both ENDS users and smokers was phase
closure with closed phase predominating. Phase closure with closed phase predominating
may be caused by hyperfunction of laryngeal structures in response to irritation or
swelling, as well as tissue changes, such as edema or the presence of lesions causing
abnormalities in phase closure. In the present study, abnormal phase closure was

59

frequently associated with increased bilateral or unilateral edema, especially in ENDS
users. This may be the result of tissue changes caused by chronic irritation from ENDS
aerosol similar to the tissue changes caused by chronic irritation from cigarette smoke
(Salturk et al., 2015; Sataloff, 2005).
In the current study, a marginally significant relationship was found between
abnormal phase symmetry and both ENDS use and smoking. This relationship between
abnormal phase symmetry and smoking is consistent with prior research, which
associated abnormal phase symmetry with the presence of vocal fold edema (Banjara et
al., 2011; Awan & Morrow, 2008). Abnormal phase symmetry in ENDS users may be
attributed to edematous vocal folds as well, or to other tissue changes that have caused
the vocal folds to have different mechanical properties.
A marginally significant relationship was found in the present study between
abnormal regularity and both ENDS use and smoking. This finding supports prior
research on the effect of smoking on vocal fold vibration (Banjara et al., 2011; Awan &
Morrow, 2008). The most frequent abnormal regularity in both groups was frequent
inconsistency of cycles observed followed by inconsistency in the type of phase closure
observed. As with asymmetry of phase, abnormality in regularity is indicative of
differences between the mechanical properties of the two vocal folds. Vocal folds that
have similar mechanical properties vibrate as mirror images of one another with
observable cycle and phase closure consistency. This abnormal finding reflects probable
changes in vocal fold tissue of ENDS users, which may be a result of chronic irritation
from toxins present in ENDS aerosol (Buron et al., 2009; U.S. EPA, 2003; Arts et al.,
2004; Farsalinos et al., 2013; Rowell & Taran, 2015).
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In the current study, no significant relationship was observed between abnormal
glottal closure and smoking or ENDS use. Earlier studies have mixed results regarding
the effect of smoking on glottal closure. Banjara et al. (2011) found no significant
difference between abnormal glottal gap findings between smoking and nonsmoking
groups; however, Awan and Morrow (2007) found a significant difference, attributing
observed differences in glottal closure to irritation of the arytenoid cartilages caused by
smoking. The most frequently occuring glottal closure patterns for both ENDS and
smoker groups was posterior gap followed by variable closure patterns. Posterior gap is a
normal closure pattern. Variable closure patterns in ENDS users may be due to chronic
irritation from ENDS aerosol altering the mechanical properties of the vocal folds.
No significant relationship was found in the present study between abnormal
amplitude and ENDS or cigarette use. Additionally, this study found no significant
relationship between abnormal vertical level and chronic ENDS aerosol or cigarette
smoke exposure. Finally, no significant relationship was found between abnormal
supraglottic activity and the smoker group. Prior research on supraglottic activity in
smokers is consistent with the present finding in smokers. Similarly, no significant
relationship was found between ENDS use and abnormal supraglottic activity; however, a
pattern of both static and dynamic supraglottic activity apparently unrelated to gag
response was observed in ENDS users. This supraglottic activity was consistent with
observations of supraglottic edema. Abnormal supraglottic activity may be due to
compensation of laryngeal structures in response to edematous and irritated vocal folds.
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Research Question 3: Are there similarities in the visual appearance of the vocal folds of
ENDS users as compared to smokers?
Results indicated that there are similarities in the visual appearance of the vocal
folds of ENDS users and cigarette smokers, including abnormal vocal fold edge contour,
varices, edema, and discoloration. In the current study, a significant relationship was
found between abnormal vocal fold edge contour and ENDS use when compared to
nonsmokers. Abnormal free edge may be the result of microscopic tissue changes
following chronic irritation or edema, or due to the presence of lesions. Abnormal free
edge contour was evident though not significant in smokers as compared to nonsmokers.
This finding is consistent with prior research on the effect of smoking on the larynx
(Banjara et al., 2011; Awan & Morrow, 2008). Banjara et al. (2011) suggested that
abnormal free edge findings in smokers is caused by chronic irritation of the vocal folds
resulting in histological changes in vocal fold epithelium as described by Sataloff (2005).
Salturk et al. (2015) discovered epithelial responses, including hyperplasia and
metaplasia, evident in the vocal folds of ENDS users. The observed changes in vocal fold
edge contour in ENDS users may be the result of similar alterations in vocal fold
epithelium caused by chronic irritation from ENDS aerosol.
In the present study, a significant relationship was observed between vocal fold
varices and both ENDS use and smoking. The appearance of vascularity is characterized
by capillary dilation or leakage, or thin red lines/veins on the vocal folds. Varices is
known to accompany edema and is caused by irritation, including smoking and chemical
exposure (Banjara et al., 2014). The current study’s finding of a significant relationship
between varices and smoking is consistent with prior studies (Banjara et al., 2014). It
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may be that the presence of vascularity in the vocal folds of ENDS users is also caused
by chronic irritation due to exposure to mucous membrane and epithelial irritants within
e-liquids and aerosol (Callahan-Lyon, 2014; Buron et al., 2009; U.S. EPA, 2003; Arts et
al., 2004; Farsalinos et al., 2013; Rowell & Taran, 2015).
Abnormal vocal fold edema showed a highly significant relationship in ENDS
users as compared to nonsmokers. A significant relationship was also found between the
presence of abnormal edema and smoking as compared to nonsmokers. The most
frequently observed vocal fold edema was the appearance of unilateral and bilateral
edema in the superficial lamina propria as well as the epithelium of ENDS users and
smokers. This edema was observed to cause reduced movement of the mucosal wave, as
well as to cause tissue within Reinke’s space to become more pliable and vibrate
differently (see Figure 1.7). Reinke’s edema is accumulation of fluid or swelling in
Reinke’s space due to chronic irritation and is highly correlated with chronic smoking
(Jain et al., 2009). The presence of possible Reinke’s edema in ENDS users in the present
study suggests that effects of ENDS aerosol on the tissue of the superficial lamina propria
are similar to that of cigarette smoke. Of note, one ENDS participant with significant
vocal fold edema presented with audible inhalation consistent with stridor and was
referred to an otolaryngologist. Stridor is the involuntary production of noise upon
inhalation and is a symptom of airway obstruction.
The present study found a significant relationship between vocal fold
discoloration and smoking. This finding is consistent with a prior study that found
increased discoloration of laryngeal structures in smokers (Awan & Morrow, 2008).
Vocal fold discoloration was evident though not significant in ENDS users. A healthy
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mucosal cover gives the vocal folds their pearl-white appearance. Vocal fold
discoloration indicates changes in the tissue of the mucosal cover, consisting of the
epithelium and superficial lamina propria or Reinke’s space. Swelling, irritation,
dehydration, and trauma to this area may cause vocal fold discoloration. It may be that
the discoloration evident in the vocal folds of ENDS users is due to dehydration,
swelling, or irritation, similarly to the effect of cigarette smoke on the mucosal cover.
Although ENDS aerosol is not produced by combustion as is cigarette smoke, toxins
within ENDS aerosol have known irritative and dehydrating qualities (Callahan-Lyon,
2014; Buron et al., 2009; U.S. EPA, 2003; Arts et al., 2004; Farsalinos et al., 2013;
Rowell & Taran, 2015).
Research Question 4: Are there similarities in the visual appearance of laryngeal
structures of ENDS users as compared to smokers?
The present study found a marginally significant increase in the presence of
ventricular fold erythema in smokers as compared to nonsmokers. This finding is
consistent with prior research that showed a significant increase in the presence of
ventricular fold erythema in smokers as compared to nonsmokers (Banjara et al., 2011).
No significant relationship was found between ventricular fold erythema and ENDS use;
however, due to the small sample size of this study, it remains possible that a relationship
may be found in studies with a larger sample.
In the current study, no significant relationship was observed between smoking or
ENDS use and arytenoid erythema or arytenoid edema; however, past studies have found
a significant relationship between smoking and arytenoid edema (Awan & Morrow,
2007). This discrepancy is likely due to the small sample size of this study. Additionally,
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no significant relationship was found between smoking or ENDS use and vocal fold
mucus; however, a pattern of of thick, white mucus was observed on three of seven
ENDS users, which was not observed on the vocal folds of smokers and nonsmokers.
Thick, opaque mucus may be caused by vocal fold tissue dehydration, irritation, or other
vocal pathology (Hsiung, 2004; Bonilha, White, Kuckhahn, Gerlach & Deliyski, 2012).
The toxins within ENDS aerosol have known irritative and dehydrating qualities;
therefore, the presence of thick, white mucus on the vocal folds of ENDS users could be
indicative of a vocal pathology. More research is necessary to be conclusive in this area.
Conclusion
The purpose of the present study was to compare the laryngeal anatomy and
physiology of ENDS users, smokers, and nonsmokers to determine whether similarities
exist in the effect of ENDS aerosol as compared to cigarette smoke. In spite of the small
sample size of this study, a pattern of similar changes in the appearance and function of
the laryngeal anatomy was observed in ENDS users and smokers. These preliminary
results suggest similarities may exist between the effect of ENDS use and smoking on the
vocal folds; however, studies of much larger sample size are required to truly evaluate
effects of ENDS on the vocal folds and make definitive determinations of safety. There
have been anecdotal suggestions by ENDS companies that ENDS is a safer alternative to
smoking. While this may be the case, based on seminal findings of this study, it may be
beneficial for individuals to exercise caution in ENDS use as they would with cigarette
use.
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Limitations and Future Research
The present study has the following limitations. First, the sample size of each
group was very small, despite a concerted effort to find greater numbers of participants.
Recruiting participants for the ENDS group with no history of prior cigarette or other
tobacco use within five years prior to data collection proved difficult. Many participants
were excluded due to occasional cigarette or marijuana use. Second, the nonsmoking
group primarily consisted of college students, which may present a confounding variable.
Many college students are known to engage in behaviors and experiences that negatively
affect the health and hygiene of the larynx, including academic stress, and poor nutrition,
hydration, and sleep habits. Further studies should consider including specific questions
regarding these behaviors on screening questionnaires.
Third, participants were not grouped by device type, frequency of use, battery
voltage, or e-liquids used. Participants were frequently unable to determine battery
voltage in order to provide information on the questionnaire. Due to the fact that research
indicates these variables may impact the toxicity of ENDS, further research should
control for these variables. Unfortunately, until ENDS are regulated and standardized,
controlling for these variables would require testing of each device and e-liquids used
rather than reliance on labeling by ENDS companies.
Fourth, participants were unable to provide details on the length of time or
number of inhalations per vaping session with confidence, and thus, frequency was often
determined by the number of sessions per day rather than number of inhalations. Future
research should include an operational definition for frequency of use rather than
depending on subjective determination by the individual participant.
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Finally, this study obtained videostroboscopic data using a rigid
strobolaryngoscope. Studies have shown that the type of laryngoscope used may impact
the amount of supraglottic activity observed on videostroboscopy. As participants did not
receive numbing spray to reduce gag reflex, it is difficult to determine whether
supraglottic activity observed is a result of cigarette or ENDS use, or whether it is due to
an activated gag reflex. Future studies should consider the use of a rhinolaryngoscope in
videostroboscopy, as evidence shows this scope is less likely to activate a gag reflex.
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Appendix A
Informed consent

Informed Consent
My name is Hilary Sample. I am a graduate student at Cleveland State University in the speech and hearing
program. I am requesting your participation in a research study. If you have any questions, please feel free to contact
my advisor, Dr. Violet Cox. She can be contacted by phone at (216) 687-6909 or by email at v.cox@csuohio.edu.
The study aims to visually describe the structures of the larynx of individuals who use electronic nicotine
delivery systems versus smokers and non-users. If you decide to participate in this study, you will be asked to do three
things: complete a questionnaire; complete assessment using the Visi-Pitch IV; and complete assessment using
videostroboscopy. With the Visi-Pitch IV, you will be asked to say “ah” into a microphone for about five seconds in
a natural voice. Your larynx will then be assessed for two to three minutes using videostroboscopy. During
videostroboscopic evaluation, you will be asked to open your mouth and stick out your tongue. Gauze will be used to
gently hold your tongue. A rigid endoscope, which is similar to a tongue depressor in feel and placement, will be
inserted into your mouth to the back of the tongue. You will be asked to say the vowels “ah” and “ee” at differing
pitches. The examination is not painful, but there is a possibility that you may gag because of the placement of the
scope. If the gag continues, the procedure will end. The total time involved for the entire process is less than one hour.
To participate, you must be between 18 and 35 years of age.
Risks associated with participation are considered to be minimal. Such risks are largely limited to
compromised confidentiality. To minimize such risks, all research documents will be secured in a locked file cabinet
in Dr. Violet Cox’s office at Cleveland State University, and in the password protected hard drives of the Visi-pitch
IV and videostroboscopy in the CSU Voice and Swallowing Lab in room 211. You may withdraw from this study at
any time without any consequence whatsoever. Only summary results may be published, presented or used for
instruction. No personal identifiers will be included in such data. You will be given $10 for participating in the study
upon arrival to the voice lab; however, there are no other direct benefits available to you as a participant in this research.
A copy of this Informed Consent will be provided to you for your records.
Please read the following: “I understand that if I have any questions about my rights as a research subject,
I can contact the Cleveland State University Institutional Review Board at (216) 687-3630.”
Your signature below means that you understand the contents of this document. You also are at least 18 years
of age. Finally, you voluntarily consent to participate in this research study.

_________________________________________

_____________________

Signature

Date

_________________________________________
Name (Printed)
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Appendix B
Questionnaire
Screening Questionnaire for Research Participants
Name: ________ Birthday: _______ Gender: _______ Date: ______________
Please check the appropriate box(es) for each question:
1. Have you had a history/diagnosis of any of the following? (check all that apply)
Acid Reflux

Polyps, nodules, contact ulcers

Asthma or allergies

Other pathologies of throat or vocal cords
___________________________________

2. Have you been sick in the last two weeks with a head cold or upper respiratory infection?
3. Do you frequently overuse your voice (yelling/screaming/talking over noise)?

YES

YES

NO

NO

4. Which of the following have you ever used at least 2x daily, 7 days/week for at least one year?
ENDS: juul, e-cig, vape, mods, pods.

Cigarettes

Other tobacco/marijuana: _______

None

5. Which of the following are you currently using at least 2x daily, 7 days/week for at least one year?
ENDS: juul, e-cig, vape, mods, pods.

Cigarettes

Other tobacco/marijuana: _______

6. If you smoke: have you vaped within the past five years?

YES

NO

7. If you smoke: for how many years have you smoked? ____________
8. If you smoke: what type/brand do you smoke? ______________________
9. If you smoke: how frequently do you smoke?
<3x per day

3-10x per day

10-20x per day

Other: _____________________

10. If you vape: for how many years have you vaped? _______________
11. If you vape: have you smoked within the past five years?

YES

NO

12. If you vape: what devices do you use? (select all that apply)
❏ Cig-a-like (same size as cigarette - disposable)

❏ Rechargeable cigalike (same size as cigarette – rechargeable)
❏ Vape pens/Mods (large/customizable batteries, advanced atomizers, refillable)
❏ Pods (less vape, rechargeable, e.g., JUUL, Suorin Drop, myblu)

13. What is the brand of your device? ______________
14. What is the voltage of your device? _____________
15. Is your device:

variable voltage or

temperature controlled? (check one)

16. If you vape: how frequently do you vape?
more than 20x/day

10-20x/day

3-10x per day

Other: _________________

17. If you vape: what nicotine strength do you use? (check box and write amount)
Low ___________

Medium _________

High ___________

No Nicotine

18. If you vape, what flavor(s) do you use? (Select all that apply)
Fruit or candy(sweet)

Tobacco

Menthol

Mint

Other: ______________

19. If you have used ENDS daily, what factors made you want to start?
ENDS are safer than cigarettes

Trendy/popular

Flavors

To quit smoking

Indoor use

Other: ___________
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None

Appendix C
Acoustic Analysis Participant Instructions

Visi-pitch IV Instuctions
“Please stand in front of the machine with the microphone about two inches from your mouth,
like this (demonstrate). When I press record, say “ah” in a natural voice for 5 seconds, at which
time I will stop the recording.”
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Appendix D
Videostroboscopy Participant Instruction

Videostroboscopy Instructions:
“Please sit in this examination chair. With your bottom far back in the chair, bring your shoulders
forward and lift your chin. Now, open your mouth wide and stick out your tongue. I’m going to
hold your tongue gently with gauze while you say “ah”. Now say “ee” in a natural voice for five
seconds. And now say “ee” in a high pitch and sustain for 5 seconds. Now say “ee” in a low
pitch and sustain for five seconds. Now say “ee” in a low pitch and glide up to a high pitch. And
finally, just breath normally for a few breaths.”
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Appendix E
Table of Acoustic Norms

Acoustic
Parameters

Females (ages 18-39)

Males (ages 18-39)

Mean

SD

Mean

SD

Fundamental
Frequency
(Hz)

214.39

26.76

106.414

13.29

Jitter
(%)

0.82%

0.28%

1.41%

0.32%

Shimmer
(%)

1.59%

0.68%

2.14%

0.63%

Appendix E: Acoustic norms for 18-39 year olds by gender
(From: Schaefer et al. 2008)
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